The study sponsored by Aesculap AG aims to evaluate the in-vivo wear behavior of the Columbus® total knee prosthesis with a focus on comparing the standard Cobalt Chromium (CoCr) version against the Advanced Surface (AS) coated variant. The termination of the trial due to slow recruitment raises concerns about market interest and the potential for competitive positioning against other knee prosthesis manufacturers. The findings could influence market adoption of the AS technology, impacting Aesculap's market share in the orthopedic implant sector. Additionally, the collaboration with Raylytic GmbH may enhance data analytics capabilities, providing a competitive edge in future product development and marketing strategies.